BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2595191)

  • 1. Therapy and rehabilitation of the floppy infant.
    Eng GD
    R I Med J (1976); 1989 Oct; 72(10):367-70. PubMed ID: 2595191
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenting a floppy infant.
    McDonald MS
    R I Med J (1976); 1989 Oct; 72(10):371-3. PubMed ID: 2595192
    [No Abstract]   [Full Text] [Related]  

  • 3. The floppy infant syndrome.
    Aronson SM
    R I Med J (1976); 1989 Oct; 72(10):349. PubMed ID: 2595188
    [No Abstract]   [Full Text] [Related]  

  • 4. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beyond type I spinal atrophy].
    Mastella C
    Assist Inferm Ric; 1999; 18(4):240-6. PubMed ID: 10833298
    [No Abstract]   [Full Text] [Related]  

  • 6. Feeding and Swallowing Problems in Infants with Spinal Muscular Atrophy Type 1: an Observational Study.
    van der Heul AMB; Cuppen I; Wadman RI; Asselman F; Schoenmakers MAGC; van de Woude DR; Gerrits E; van der Pol WL; van den Engel-Hoek L
    J Neuromuscul Dis; 2020; 7(3):323-330. PubMed ID: 32333596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Global management of infantile spinal muscular atrophy. Practical guide for medical staff].
    Delmas MC; Bérard C
    Pediatrie; 1990; 45(7-8):457-64. PubMed ID: 2170920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Werdnig-Hoffmann amyotrophy in a 7-month-old child].
    Kutafin IuF; Osipov SM
    Pediatriia; 1990; (4):91-3. PubMed ID: 2371136
    [No Abstract]   [Full Text] [Related]  

  • 9. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of floppy children in Indian scenario.
    Dua T; Das M; Kabra M; Bhatia M; Sarkar C; Arora S; Sharma MC; Kalra V
    Indian Pediatr; 2001 Nov; 38(11):1236-43. PubMed ID: 11721063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hypotonic infant: how limp is too limp?].
    Kerstjens JM; Bos AP; van Gils JF; Fetter WP
    Ned Tijdschr Geneeskd; 1993 May; 137(18):889-91. PubMed ID: 8492830
    [No Abstract]   [Full Text] [Related]  

  • 13. Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.
    Xiao L; Chiang J; Amin R
    Sleep Med; 2021 Oct; 86():113-115. PubMed ID: 34253462
    [No Abstract]   [Full Text] [Related]  

  • 14. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.
    Bertini E; Gadisseux JL; Palmieri G; Ricci E; Di Capua M; Ferriere G; Lyon G
    Am J Med Genet; 1989 Jul; 33(3):328-35. PubMed ID: 2801766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene replacement therapy for spinal muscular atrophy unmasking occult hepatitis C in a pediatric patient.
    Lakhotia A; Turek G; Green J; Khan M
    Muscle Nerve; 2022 Jan; 65(1):E2-E3. PubMed ID: 34644404
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
    Kirschner J; Butoianu N; Goemans N; Haberlova J; Kostera-Pruszczyk A; Mercuri E; van der Pol WL; Quijano-Roy S; Sejersen T; Tizzano EF; Ziegler A; Servais L; Muntoni F
    Eur J Paediatr Neurol; 2021 Jan; 30():103-104. PubMed ID: 33640649
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spinal muscular atrophy in young infants].
    Smit LM; Hageman EG
    Tijdschr Kindergeneeskd; 1989 Jun; 57(3):102-6. PubMed ID: 2799798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.
    Beri N; Kapoor L; Parashar D; Mundada V
    Arch Dis Child; 2023 Oct; 108(10):866-867. PubMed ID: 37553206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
    Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
    Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.